Prevalence and sort of pharmacokinetic drug–drug interactions in hospitalized psychiatric patients

A comparison of potential psychiatric drug interactions from six drug interaction database programs

(2019) Scott Monteith et al.   PSYCHIATRY RESEARCH

Psychopharmacological Treatment of Schizophrenia over time in 30,908 inpatients – Data from the AMSP study

(2019) Sermin Toto et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Clinical relevance of alerts from a decision support system, PHARAO, for drug safety assessment in the older adults

(2019) Khedidja Hedna et al.   BMC Geriatrics

Possible Pharmacodynamic and Pharmacokinetic Drug-Drug Interactions That Are Likely to Be Clinically Relevant and/or Frequent in Bipolar Disorder

(2018) Jose de Leon et al.   Current Psychiatry Reports

Potentially Inappropriate Medications in the Elderly

(2018) Stefanie Holt et al.   Deutsches Arzteblatt International

Why Do You Keep Telling Me That Drug-Drug Interactions Are Important in Psychopharmacology When I Do Not See Them in My Clinical Practice?

(2018) Jose de Leon   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017

(2017) C. Hiemke et al.   PHARMACOPSYCHIATRY

Pharmacokinetic considerations in antipsychotic augmentation strategies: How to combine risperidone with low-potency antipsychotics

(2017) Michael Paulzen et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Prevalence of and factors associated with antipsychotic polypharmacy in patients with serious mental illness: Findings from a cross-sectional study in an upper-middle-income country

(2017) Kerryn S. Armstrong et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

Assessing drug-drug interactions through therapeutic drug monitoring when administering oral second-generation antipsychotics

(2016) Edoardo Spina et al.   Expert Opinion on Drug Metabolism & Toxicology

A Prescription for “Deprescribing” in Psychiatry

(2016) Swapnil Gupta et al.   PSYCHIATRIC SERVICES

Melperone but not bisoprolol or metoprolol is a clinically relevant inhibitor of CYP2D6: evidence from a therapeutic drug monitoring survey

(2015) Gudrun Hefner et al.   JOURNAL OF NEURAL TRANSMISSION

The clinical potentials of adjunctive fluvoxamine to clozapine treatment: a systematic review

(2015) Christoffer Polcwiartek et al.   PSYCHOPHARMACOLOGY

Effect of Proton Pump Inhibitors on the Serum Concentrations of the Selective Serotonin Reuptake Inhibitors Citalopram, Escitalopram, and Sertraline

(2015) Caroline Gjestad et al.   THERAPEUTIC DRUG MONITORING

Efectos de los inductores antiepilépticos en la neuropsicofarmacología: una cuestión ignorada. Parte I: Resumen para los clínicos de la situación actual

(2015) Jose de Leon   Revista de Psiquiatria y Salud Mental

The prevalence of co-prescription of clinically relevant CYP enzyme inhibitor and substrate drugs in community-dwelling elderly Australians

(2014) K. P. Kerr et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Severe Adverse Drug Events Under Combination of Nortriptyline and Melperone Due to Pharmacokinetic Interaction

(2014) Gudrun Hefner et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Prevalence and Risk of Potential Cytochrome P450–Mediated Drug-Drug Interactions in Older Hospitalized Patients with Polypharmacy

(2013) Julie Doan et al.   ANNALS OF PHARMACOTHERAPY

Clinical relevance of the (S)-citalopram-omeprazole interaction in geriatric patients

(2013) Roberto Lozano et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Exposure to Potentially Dangerous Drug-Drug Interactions Involving Antipsychotics

(2013) Jeff Jianfei Guo et al.   PSYCHIATRIC SERVICES

Elevated clozapine serum levels in combination with perazine

(2013) M. Fischer et al.   PSYCHOPHARMACOLOGY

Comparative evaluation of three clinical decision support systems: prospective screening for medication errors in 100 medical inpatients

(2012) Daniela Fritz et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Perpetrators of pharmacokinetic drug-drug interactions arising from altered cytochrome P450 activity: a criteria-based assessment

(2011) Thomas M. Polasek et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Evaluation of Drug Interactions in a Large Sample of Psychiatric Inpatients: A Data Interface for Mass Analysis With Clinical Decision Support Software

(2011) P Haueis et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The importance of drug–drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France

(2011) Francois Montastruc et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Evaluation of drug interactions and dosing in 484 neurological inpatients using clinical decision support software and an extended operational interaction classification system (Zurich Interaction System)

(2011) Markus Guzek et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Adverse Drug Reactions in Hospitalized Psychiatric Patients

(2010) Michele Thomas et al.   ANNALS OF PHARMACOTHERAPY

Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers

(2010) Adriana Rocha et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Pharmacokinetic Interaction Between Zolpidem and Carbamazepine in Healthy Volunteers

(2010) Laurian Vlase et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Clinically Relevant Pharmacokinetic Interaction Between Venlafaxine and Bupropion

(2010) Georgios Paslakis et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

The Effect of Coadministration of Duloxetine on Steady-State Serum Concentration of Risperidone and Aripiprazole: A Study Based on Therapeutic Drug Monitoring Data

(2010) Magnhild Hendset et al.   THERAPEUTIC DRUG MONITORING

Drug Interaction Can Lead to Undetectable Serum Concentrations of Quetiapine in the Presence of Carbamazepine

(2009) Thomas Nickl-Jockschat et al.   CLINICAL NEUROPHARMACOLOGY

O-demethylation of codeine to morphine inhibited by low-dose levomepromazine

(2009) M. Vevelstad et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Depressive Illness Burden Associated With Complex Polypharmacy in Patients With Bipolar Disorder

(2009) Joseph F. Goldberg et al.   JOURNAL OF CLINICAL PSYCHIATRY

Perazine elevates clozapine serum levels by inhibiting hepatic metabolism

(2009) Gerd Schaller et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Pharmacokinetic and Pharmacodynamic Interactions Between Carbamazepine and Aripiprazole in Patients With Schizophrenia

(2009) Akifumi Nakamura et al.   THERAPEUTIC DRUG MONITORING

Influence of Comedication on Serum Concentrations of Aripiprazole and Dehydroaripiprazole

(2009) Ragnhild Birkeland Waade et al.   THERAPEUTIC DRUG MONITORING

Impact of Multiple Inhibitors or Substrates of Cytochrome P450 2D6 on Plasma Risperidone Levels in Patients on Polypharmacy

(2008) Buster Mannheimer et al.   THERAPEUTIC DRUG MONITORING